Biblio Discovery — Demo Discovery Service

20 results for "Burhan Ferhanoğlu"

Showing 1–20 · 1.43 seconds · RSS

  1. Journal Article

    Inflammatory myofibroblastic tumor mimicking a relapse in a patient with Hodgkin's lymphoma: report of an unusual case and review of the literature

    Murat Özbalak; Ege Sinan Torun; Metin Özdemirli et al.

    Clinical Case Reports, Vol. 5 No. 6 · 2017 · English · DOAJ Dropped by Scopus 2021

    Key Clinical Message New PET‐positive lesions in previously treated patients with lymphomatous malignancies need further investigations. Relapse, sarcoidosis and secondary malignancies are the most important differential diagnosis. Inflammatory myofibroblastic tumors (IMT) is a rare complication…

  2. Journal Article

    Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options

    Güven Çetin; Ahmet Emre Eşkazan; M. Cem Ar et al.

    Turkish Journal of Hematology, Vol. 31 No. 4 · 2014 · English · DOAJ Scopus

    OBJECTIVE: This study aimed to investigate the impact of the different therapy regimens used in multiple myeloma (MM) on bone-specific alkaline phosphatase (BALP) levels. METHODS: One hundred and thirteen patients with MM were included in the study. Patients were grouped according to the regimens…

  3. Journal Article

    The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

    M. Cem Ar; Deram Büyüktaş; A. Emre Eşkazan et al.

    Turkish Journal of Hematology, Vol. 29 No. 3 · 2012 · English · DOAJ Scopus

    OBJECTIVE: Bone marrow fibrosis is the second most common complication causing morbidity and mortality in patients with Philadelphia negative myeloproliferative neoplasms (MPNs). The aim of this study was to investigate the association of JAK2V617F mutation with the bone marrow (BM) fibrosis at…

  4. Journal Article

    Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode

    Aslıhan Demirel; Fehmi Tabak; M. Cem Ar et al.

    Turkish Journal of Hematology, Vol. 32 No. 3 · 2015 · English · DOAJ Scopus

    INTRODUCTION: Febrile neutropenic episodes (FNEs) are among major causes of mortality in patients with hematological malignancies. Secondary infections develop either during the empirical antibiotic therapy or one week after cessation of therapy for a FNE. The aim of the study was to investigate…

  5. Journal Article

    Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study

    Sibel Işlak Mutcalı; Neşe Saltoğlu; İlker İnanç Balkan et al.

    Turkish Journal of Hematology, Vol. 33 No. 4 · 2016 · English · DOAJ Scopus

    Objective: The significance of mannose-binding lectin (MBL) and H-ficolin deficiency in febrile neutropenic (FN) patients and the correlation of these markers along with consecutive C-reactive protein (CRP) and procalcitonin (PCT) levels during the infectious process are investigated. Materials and…

  6. Journal Article

    Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report

    Havva Sezer; Dilek Yazıcı; Serdar Tezelman et al.

    Indian Journal of Pathology and Microbiology, Vol. 64 No. 1 · 2021 · English · DOAJ Scopus

    Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most common adult leukemia. The coexistence of CLL and papillary thyroid carcinoma (PTC) is extremely rare. PTC sometimes shows microscopic vascular invasion but rarely cause a tumor thrombus in the internal jugular vein…

  7. Journal Article

    The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients

    Mücahit Yemişen; İlker İnanç Balkan; Ayşe Salihoğlu et al.

    Turkish Journal of Hematology, Vol. 33 No. 3 · 2016 · English · DOAJ Scopus

    Objective: Patients receiving hematopoietic stem cell transplantation (HSCT) are exposed to highly immunosuppressive conditions and bloodstream infections (BSIs) are one of the most common major complications within this period. Our aim, in this study, was to evaluate the epidemiology of BSIs in…

  8. Journal Article

    Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study

    David Brittain; Saad Akhtar; Sylvia Rodrigues et al.

    Turkish Journal of Hematology, Vol. 41 No. 4 · 2024 · English · DOAJ Scopus

    Objective: B-HOLISTIC was a real-world retrospective study of treatment patterns and clinical outcomes in Hodgkin lymphoma (HL) in regions outside Europe and North America. This subgroup analysis reports findings from Saudi Arabia, Türkiye, and South Africa. Materials and Methods: Patients aged ≥18…

  9. Journal Article

    Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

    Murat Özbalak; Metban Mastanzade; Dilek Özden Özlük et al.

    Turkish Journal of Hematology, Vol. 39 No. 4 · 2022 · English · DOAJ Scopus

    Objective: Redditux® (RED), as a biosimilar rituximab, was approved in Turkey for all indications of the original Mabthera® (MAB) in March 2018. The aim of our study was to evaluate the efficacy and safety of RED in de novo diffuse large B-cell lymphoma. Materials and Methods: Fifty-one patients…

  10. Journal Article

    Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

    Ebru Erdoğan; Koray Yalçın; Cansu Hemşinlioğlu et al.

    Turkish Journal of Hematology, Vol. 39 No. 3 · 2022 · English · DOAJ Scopus

    Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability and sustainability. In this preliminary study…

  11. Journal Article

    A Large Room for Improvement in the Management of Relapsed/ Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies

    Umut Yılmaz; Mehmet Sinan Dal; Turgay Ulaş et al.

    Turkish Journal of Hematology, Vol. 42 No. 4 · 2025 · English · DOAJ Scopus

    Objective: Patients with large B-cell lymphoma (LBCL) who are relapsed/refractory (R/R) after frontline therapy have traditionally experienced highly unfavorable outcomes. The development of T-cell redirecting therapies is rapidly changing that outlook, but costs and infrastructural challenges…

  12. Journal Article

    Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

    Anıl Tombak; Funda Pepedil Tanrıkulu; Salih Sertaç Durusoy et al.

    Turkish Journal of Hematology, Vol. 38 No. 4 · 2021 · English · DOAJ Scopus

    Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +- standard deviation: 64.6+-10.3 years, 66.9% males) who had…